84. サルコイドーシス Sarcoidosis Clinical trials / Disease details


臨床試験数 : 149 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00851929
(ClinicalTrials.gov)
November 200824/2/2009Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary HypertensionAmbrisentan (Letairis) for Sarcoidosis Associated Pulmonary HypertensionSarcoidosis;Pulmonary HypertensionDrug: AmbrisentanMedical University of South CarolinaGilead SciencesCompleted18 Years99 YearsAll16Phase 2/Phase 3United States